V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 20186229 | 20089040 | 1.77 | 68.4 | Palliative (P) | null | 2019-08-22 | Letrozole + Palbociclib | 01 | N | CAP + RT | 100923727 |
| 20187912 | 20089041 | null | null | 03 | 2019-11-14 | 2019-11-14 | Carboplatin+Fluorouracil 4 or 5 day | 02 | N | CISPLATIN + VINORELBINE | 101522207 |
| 20188060 | 20089042 | 1.74 | 64.1 | null | 2018-07-03 | 2018-07-03 | null | 02 | N | INTERAACT TRIAL | 100281128 |
| 20189566 | 20089043 | 1.7 | 65.2 | Palliative (P) | 2018-12-06 | 2018-12-14 | Radium 223 | 99 | N | EPIRUBICIN + FLUOROURACIL + OXALIPLATIN | 100447683 |
| 20190352 | 20089045 | 1.87 | 101 | Palliative (P) | 2019-08-04 | 2019-08-06 | LENALIDOMIDE | 02 | N | IXAZOMIB + LENALIDOMIDE | 101072858 |
| 20195271 | 20089047 | 1.68 | 36.9 | 03 | 2020-10-14 | 2020-10-23 | Doxorubicin + Ifosfamide | 02 | N | EVEROLIMUS | 100021107 |
| 20199330 | 20089049 | 1.73 | null | 03 | 2016-08-07 | 2016-08-14 | FCiSt | N | N | AZACITIDINE | 100822130 |
| 20199357 | 20089050 | 1.78 | 72.4 | null | 2019-07-25 | 2019-07-31 | Rituximab (Maintenance) | N | N | ACELARATE TRIAL | 100441603 |
| 20200913 | 20089051 | 1.75 | 115 | null | 2020-02-24 | 2020-02-24 | MITOMYCIN | 02 | N | FCIST | 100060037 |
| 20201838 | 20089054 | 0 | 73.3 | 03 | 2020-01-05 | 2020-01-05 | null | 02 | N | CYCLOPHOSPHAMIDE + RITUXIMAB + VINCRISTINE | 101521517 |
| 20201996 | 20089055 | 1.75 | 92.6 | Palliative (P) | 2019-05-07 | 2019-07-10 | GEM-P | null | N | NAB-PACLITAXEL | 100489506 |
| 20204646 | 20089056 | 1.73 | 63.5 | Palliative (P) | 2022-03-21 | 2022-03-21 | GemCarbo Days 1+8 | 02 | N | FLUOROURACIL + RT | 101654137 |
| 20204722 | 20089057 | 1.53 | 107.7 | 03 | 2017-08-10 | 2017-08-17 | CETUXIMAB + RT | 02 | N | SCOPE2 TRIAL | 100936390 |
| 20205619 | 20089058 | 1.65 | 61.1 | Neo-adjuvant (N) | 2018-10-14 | 2018-10-16 | ARISTOTLE TRIAL | 01 | N | ESPAC TRIAL | 101747743 |
| 20210629 | 20089061 | 1.86 | 75.6 | 03 | 2019-12-21 | 2019-12-23 | Hepatoblastoma SR PLADO | 02 | N | ARISTOTLE TRIAL | 101794725 |
| 20210958 | 20089062 | 1.78 | 83.6 | Adjuvant (A) | 2018-08-12 | 2018-08-14 | BCG Intravesical | 02 | null | CYCLOPHOSPHAMIDE + THALIDOMIDE | 100639536 |
| 20211066 | 20089063 | 1.54 | 78.1 | Adjuvant (A) | 2019-12-01 | 2019-12-01 | Carboplatin + Pemetrexed | 02 | N | CYCLOPHOSPHAMIDE + DOCETAXEL + EPIRUBICIN | 100559799 |
| 20211488 | 20089065 | 1.82 | 88.3 | Adjuvant (A) | null | 2020-01-28 | Cisplatin + Radiotherapy | 01 | N | BORTEZOMIB + THALIDOMIDE | 101119237 |
| 20212094 | 20089066 | 1.67 | null | 03 | 2017-03-29 | 2017-03-29 | DABRAFENIB + TRAMETINIB | 02 | N | EOF | 100203168 |
| 20212159 | 20089067 | 1.68 | 63.7 | 03 | 2016-04-28 | 2016-05-28 | Irinotecan | 02 | null | ACTICCA-1 TRIAL | 100016305 |
| 20214327 | 20089068 | null | 73.9 | null | 2020-05-05 | 2020-05-19 | null | 01 | N | IBRUTINIB | 101542315 |
| 20215936 | 20089069 | 1.55 | 65 | 03 | 2019-09-05 | 2019-09-16 | Cisplatin + Docetaxel +Fluorouracil | 02 | Y | ECARBOX | 101630201 |
| 20216714 | 20089070 | 1.57 | 87 | 03 | 2019-11-22 | 2019-12-26 | Cisplatin +FU +Trastuzumab - Load | 02 | Y | ACTICCA-1 TRIAL | 101092613 |
| 20219760 | 20089072 | 1.82 | 94 | 03 | 2017-12-31 | 2018-01-07 | Panitumumab | 02 | Y | FLUOROURACIL + RT | 100369989 |
| 20220027 | 20089073 | 1.43 | 100 | 03 | 2018-10-15 | 2018-10-19 | BALLAD Trial | N | N | ACTICCA-1 TRIAL | 101100293 |
| 20220787 | 20089074 | 1.66 | 62.7 | 03 | 2015-09-24 | 2015-10-19 | MIC | 02 | N | HEP HR HEPATOBLASTOMA GUIDE CISP | 101289717 |
| 20224374 | 20089077 | 1.64 | 72 | null | 2019-05-16 | 2019-05-23 | Bortezomib + MELPHALAN | 02 | N | HYDROXYCARBAMIDE | 100532288 |
| 20225316 | 20089078 | 1.71 | 64 | Palliative (P) | 2018-04-25 | 2018-05-02 | Bortezomib (weekly) | 02 | null | GEMCARBO | 101453265 |
| 20015711 | 20089080 | 1.66 | null | Palliative (P) | null | 2019-11-06 | Cladribine (subcut) 5 days | N | N | CARBOPLATIN + PEMETREXED | 101583233 |
| 20024555 | 20089082 | 0 | 0 | 03 | null | 2016-07-05 | PLATO Trials | 2 | N | PLATO TRIAL | 101122635 |
| 20039175 | 20089083 | 1.75 | 81.05 | 03 | null | 2018-09-09 | EVEROLIMUS | 02 | N | CARBOPLATIN + FLUOROURACIL | 100058274 |
| 20046077 | 20089084 | 0 | 0 | Palliative (P) | 2019-01-01 | 2019-01-10 | CYCLOPHOSPHAMIDE + RITUXIMAB + Dexamethasone | 02 | N | CYCLOPHOSPHAMIDE + DOXORUBICIN + VINCRISTINE | 100829353 |
| 20046135 | 20089085 | 1.83 | 107.5 | 03 | null | 2020-03-17 | ECarboX | N | N | GEMCITABINE + PACLITAXEL | 100166988 |
| 20048490 | 20089086 | 1.53 | 82 | Palliative (P) | null | 2017-04-26 | Carboplatin+Fluorouracil 4 or 5 day | 1 | N | IDARUBICIN + METHOTREXATE + VINCRISTINE | 100913682 |
| 20056056 | 20089088 | 1.6 | 56.3 | Palliative (P) | 2020-02-17 | 2020-03-02 | EEF or EOF | 02 | N | GO2 TRIAL | 101725014 |
| 20070602 | 20089092 | 1.85 | 94.5 | null | null | 2016-10-16 | CISPLATIN + TEYSUNO | 2 | N | OXALIPLATIN | 101417571 |
| 20073243 | 20089093 | 1.76 | 90 | 03 | 2019-07-01 | 2019-07-04 | Raltitrexed | 02 | N | CISPLATIN + TEYSUNO | 100198859 |
| 20105537 | 20089096 | 1.57 | 76 | Palliative (P) | 2020-02-07 | 2020-02-07 | CARBOPLATIN + FLUOROURACIL | 02 | null | CISPLATIN + RT | 101617834 |
| 20111420 | 20089097 | 1.75 | 68 | 03 | 2018-05-31 | 2018-06-30 | CARBOPLATIN + FLUOROURACIL | N | N | DOXORUBICIN | 100714159 |
| 20127088 | 20089099 | 1.69 | 63.7 | Palliative (P) | null | 2018-10-20 | PLATO Trials | 02 | N | PLATO TRIAL | 101298075 |
| 20205657 | 20089102 | 1.57 | 83.8 | 03 | 2019-09-18 | 2019-09-25 | Paclitaxel 7 day | N | N | CLADRIBINE | 101761467 |
| 20210958 | 20089104 | null | 69.4 | Palliative (P) | null | 2018-02-13 | null | 99 | N | AZACITIDINE | 100639536 |
| 20225316 | 20089106 | 1.85 | 40.4 | Palliative (P) | 2019-10-11 | 2019-10-12 | Raltitrexed | 02 | N | RITUXIMAB | 101453265 |
| 20048721 | 20089107 | 1.66 | 47 | Palliative (P) | 2020-05-15 | 2020-05-15 | Gemcitabine+Paclitaxel (Neo-tAnGo) | 02 | N | BORTEZOMIB + MELPHALAN | 101266698 |
| 20124542 | 20107147 | 1.6 | 60.5 | Palliative (P) | null | 2019-02-27 | Capecitabine + Oxaliplatin 21day | 02 | N | CAPECITABINE + OXALIPLATIN | 100449792 |
| 20124548 | 20107148 | 1.75 | 58.7 | null | 2017-10-13 | 2017-10-20 | CAPECITABINE + OXALIPLATIN | 02 | N | CAPECITABINE + OXALIPLATIN | 100299028 |
| 20124551 | 20107149 | 1.75 | 59 | null | 2016-06-24 | 2016-06-24 | Capecitabine + Oxaliplatin 21day | 02 | null | CAPECITABINE + OXALIPLATIN | 101565498 |
| 20124552 | 20107150 | 1.62 | 65.3 | Curative (C) | 2018-04-05 | 2018-09-10 | CAPECITABINE + OXALIPLATIN | N | N | CAPECITABINE + OXALIPLATIN | 101837730 |
| 20124553 | 20107151 | 1.84 | 60.1 | Curative (C) | 2020-02-05 | 2020-04-01 | CAPECITABINE + OXALIPLATIN | N | N | CAPECITABINE + OXALIPLATIN | 100474915 |
| 20124554 | 20107152 | 1.66 | 88.8 | Palliative (P) | null | 2017-12-02 | Capecitabine + Oxaliplatin 21day | 02 | null | CAPECITABINE + OXALIPLATIN | 100250599 |